InvestorsHub Logo
icon url

Couch

06/15/16 9:12 AM

#205184 RE: namtae #205178

Gee you mean besides POSITIVE BE, HAL & Efficacy Data. LMAO
icon url

COO2002COO

06/15/16 10:09 AM

#205210 RE: namtae #205178

"When we receive a PDUFA date from the FDA, we do expect that we will have a priority review. Several of you were asking: are you confident that you will get a priority review? What I can tell you is this: This is not an Elite special. This is not something that we did, that the FDA is doing for Elite. The FDA’s policy is very simple. Anybody that files an ADF formulation will get the priority review. And during our correspondence with FDA we told them, do we qualify and they said, if you are telling us is the truth, basically once we look at the application we will make that determination but from what you told us it sounds like you qualify for priority review. I am confident that we qualify for priority review because our technology uses the pharmacological approach and it is abuse deterrent. And when we hear an official response from FDA we will definitely notify the stockholders.

............I don’t want any surprises, I don’t want a question from the FDA, I don’t want any delays, and therefore we’re not going to take any chances and we’re going to wait. And to give you an example on here, Pfizer filed their Oxy BID and they got priority review and the FDA at the end of the prior review said we would need three more months to discuss it further and after the three months, they also needed some more time because has not disclosed. "

Hope the above info from the last CC can give you some ideas.

http://seekingalpha.com/article/3885716-elite-pharmaceuticals-eltp-ceo-nasrat-hakim-q3-2016-results-earnings-call-transcript?part=single
icon url

Investormax2009

06/15/16 11:53 AM

#205242 RE: namtae #205178

Please tell us what you mean when you say we may be overlooking data purposefully? I do not think investors would purposefully invest their money in a company that they knew had issues and at the same time refused to recognize them in their investment.

Max